Regeneron Pharmaceuticals, Inc.
METHOD OF DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS
Last updated:
Abstract:
The present disclosure relates to the use of an anti-IL6 receptor antibody for treating rheumatoid arthritis in subjects with serum concentrations of certain biomarkers.
Status:
Application
Type:
Utility
Filling date:
24 Apr 2020
Issue date:
31 Dec 2020